Applied DNA Sciences (NASDAQ:APDN) Issues Quarterly Earnings Results

Applied DNA Sciences (NASDAQ:APDN) posted its quarterly earnings data on Thursday. The technology company reported ($0.56) earnings per share for the quarter, missing the consensus estimate of ($0.32) by ($0.24), Zacks reports. Applied DNA Sciences had a negative net margin of 203.76% and a negative return on equity of 111.18%.

Applied DNA Sciences Price Performance

Shares of NASDAQ:APDN traded down $0.02 on Thursday, reaching $0.17. The company’s stock had a trading volume of 3,717,359 shares, compared to its average volume of 3,093,090. Applied DNA Sciences has a 52-week low of $0.12 and a 52-week high of $14.40. The stock’s 50-day moving average is $0.19 and its two-hundred day moving average is $0.52. The stock has a market capitalization of $9.61 million, a P/E ratio of -0.03 and a beta of 0.37.

Applied DNA Sciences Company Profile

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.